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Melanocytes, after cell division, separate and migrate along the basement membrane; they extend their dendrites
and establish multiple contacts with keratinocytes. Once adhesion is established, keratinocytes control me-
lanocyte growth and expression of cell surface receptors. Most melanomas arise within the epidermis (melanoma
in situ) and then invade across the basement membrane. These melanoma cells escape from control by keratin-
ocytes through ﬁve major mechanisms: (1) downregulation of receptors important for communication with ker-
atinocytes such as E-cadherin, P-cadherin, and desmoglein, which is achieved through growth factors such as
hepatocyte growth factor, platelet-derived growth factor, and endothelin-1 produced by ﬁbroblasts or keratin-
ocytes; (2) upregulation of receptors and signaling molecules important for melanoma cell–melanoma cell and
melanoma cell–ﬁbroblast interactions such as N-cadherin, Mel-CAM, and zonula occludens protein-1; (3) dereg-
ulation of morphogens such as Notch receptors and their ligands; (4) loss of anchorage to the basement membrane
because of an altered expression of cell–matrix adhesion molecules; (5) increased elaboration of metal-
loproteinases. Thus, investigating normal melanocyte homeostasis helps us to better deﬁne how melanoma cells
escape the microenvironment created by epidermal keratinocytes and how they develop new cellular partners in
ﬁbroblasts and endothelial cells, which support their growth and invasion.
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In multicellular organisms, homeostasis is governed by ei-
ther endocrine and paracrine communication via soluble
factors including hormones, growth factors, and cytokines;
or by intercellular communication via cell–cell and cell–ma-
trix adhesion, and gap junctional intercellular communica-
tion (GJIC) (reviewed in Haass et al, 2004, 2005a). The
characteristics of solid tumors, i.e., uncontrolled prolifera-
tion, derangement of cellular and morphological differenti-
ation, invasion, and colonization to distant organs, can be
attributed, in part, to alterations in intercellular communi-
cation between neoplastic cells and normal cells in their
microenvironment (e.g., Hanahan and Weinberg, 2000; Park
et al, 2000). Our laboratory is investigating melanocyte
homeostasis in normal skin to gain a better understanding
of deregulated growth patterns in melanomas because
cancer is generally viewed as a result of the disruption of
homeostatic regulations, which determine whether cells re-
main quiescent, proliferate, differentiate, or die.
The epidermal melanin unit of the human epidermis de-
notes the symbiotic relationship in which one melanocyte
transports pigment-containing melanosomes through its
dendrites to approximately 36 associated keratinocytes
(Fitzpatrick and Breathnach, 1963; Jimbow et al, 1976). In
this unit, melanocytes are located in the basal layer of the
epidermis, where they keep a life-long stable ratio of 1:5
with basal keratinocytes (Fitzpatrick et al, 1979). This
balance is maintained through regulated induction of me-
lanocyte division and is only disturbed during trans-
formation into a nevus or a melanoma. During childhood,
i.e., during expansion of the total skin surface, there is a
continuous need for melanocyte proliferation to maintain a
stable ratio with the basal keratinocytes. In order to prolif-
erate, melanocytes need to decouple from the basement
membrane and from the keratinocytes, retract their dend-
rites, divide, and migrate along the basement membrane
before they finally recouple to the matrix and to keratin-
ocytes to form another epidermal melanin unit. The half-life
of melanocytes is not well understood. But we assume that
melanocytes during adulthood continue to proliferate albeit
at a low rate and only upon specific stimulation such as
sunlight exposure or wounding.
Physiologically, homeostasis determines whether a cell
remains quiescent, proliferates, differentiates, or undergoes
apoptosis (Bissell and Radisky, 2001). Dysregulation of the
homeostasis may disturb the balance of the epidermal
melanin unit and trigger a continuous proliferation of the
melanocytes, which may lead to the development of mel-
anoma. Hallmarks for melanoma cells include independence
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from exogenous growth factors through the production
of autocrine growth factors or the constitutive activation of
growth factor-related signaling cascades, unlimited life
span, escape from control by keratinocytes, unresponsive-
ness to inhibitory growth factors such as transforming
growth factor-b (TGF-b), invasion into the dermis, recruit-
ment of fibroblasts for matrix and growth factor production,
and recruitment of a neovasculature (Hanahan and Weinb-
erg, 2000). It is likely that melanoma cells escape from con-
trol by keratinocytes through the following mechanisms: (1)
downregulation of receptors important for communication
with keratinocytes, (2) upregulation of receptors and signa-
ling molecules important for melanoma cell–melanoma cell
and melanoma cell–fibroblast interactions, (3) deregulation
of morphogens that directed them during development to
the epidermis and helped maintain their proper position, (4)
loss of anchorage to the basement membrane because of
an altered expression of cell–matrix adhesion molecules,
and (5) increased elaboration of metalloproteinases.
In this review we will focus on different steps during me-
lanocyte proliferation within the complex microenvironment
of the epidermis and how such studies help us to under-
stand development of melanoma and its progression.
E-Cadherin-Mediated Regulation of
Melanocytes
Under normal conditions in the epidermis, E-cadherin is
expressed on the cell surface of both keratinocytes and
melanocytes, and is the major adhesion molecule between
epidermal melanocytes and keratinocytes (Tang et al, 1994;
Hsu et al, 1996). Keratinocytes play an essential role in
regulating melanocyte proliferation and differentiation (Hsu
et al, 2000b). Normal melanocytes in vitro in monoculture
have a cell surface phenotype similar to melanoma cells,
i.e., they express most melanoma-associated antigens
(Valyi-Nagy et al, 1993; Shih et al, 1994; Hsu et al, 2000b).
When melanocytes are co-cultured with undifferentiated
keratinocytes, expression of melanoma-associated anti-
gens such as Mel-CAM and avb3 integrin is lost within 3–4 d,
suggesting that the keratinocytes control cell surface mol-
ecules on the melanocytes (Shih et al, 1994). When kera-
tinocytes and melanocytes are seeded together at a fixed
ratio and allowed to proliferate, the original ratio remains
constant during proliferation of both cell types, suggesting
that the keratinocytes regulate their equilibrium with the
melanocytes (Valyi-Nagy et al, 1993). These regulatory ac-
tivities of keratinocytes occur through direct epidermal-
specific cell–cell contact and not through soluble factors
(Valyi-Nagy et al, 1993; Shih et al, 1994; Hsu et al, 2000b). E-
cadherin is the most critical molecule that mediates kera-
tinocyte–melanocyte interaction because melanocytes not
expressing E-cadherin are not regulated by keratinocytes
(Tang et al, 1994). Besides E-cadherin-mediated adherens
junctions, desmosomes (maculae adhaerentes) are believed
to play an important role in maintaining human skin home-
ostasis (Garrod, 1993). Reduced expression or switches of
isoforms of desmosomal components seem to play a role in
tumor progression (Tselepis et al, 1998; Chidgey, 2002). Al-
though there are no desmosomes present in melanocytes,
desmoglein 1 (Dsg1) is expressed in melanocytes and
downregulated during melanoma genesis (Li et al, 2001b).
Dsg1 has a similar expression pattern to E-cadherin and is a
co-receptor for E-cadherin (Li et al, 2001b).
Most melanoma cells have lost expression of E-cadherin
and instead have upregulated the expression of N-cadherin.
This switch in cadherins is also known to change the bind-
ing partners of melanocytes from keratinocytes, so that they
preferentially associate with fibroblasts and vascular end-
othelial cells (Hsu et al, 1996). These findings have been
confirmed by clinical studies, which showed that both E-
cadherin and P-cadherin are lost from vertical growth phase
(VGP)-stage melanoma, with some samples also exhibiting
increased N-cadherin expression (Sanders et al, 1999). On
the other hand it has been shown in vitro and in vivo that E-
cadherin is not always decreased in melanoma cells (Kren-
gel et al, 2004; Tsutsumida et al, 2004). Our RT-PCR studies
on 35 melanoma cell lines, revealed a number, which ex-
pressed both E- and N-cadherin at RNA level (Smalley et al,
2005). Most of the cell lines, which expressed E-cadherin at
the RNA level, were radial growth phase (RGP) and early
VGP melanomas. From these, a number of melanomas,
which expressed E-cadherin at the RNA level, were tested
for E-cadherin protein expression. Three out of the selected
five melanoma cell lines, WM35, WM164, and WM1232
were found to express both E- and N-cadherin. But it was
found in the WM35 and WM1232 cell lines that only N-
cadherin was located at cell–cell adhesions. The expressed
E-cadherin was largely restricted to cytoplasmic pools and
thus not functional as an adhesion molecule (Smalley et al,
2005). Forced E-cadherin expression in melanoma cells,
achieved by gene transfer, restores keratinocyte-mediated
control, such as coordinated proliferation and downregulation
of metastasis-related molecules Mel-CAM and avb3 integrin
(Hsu et al, 2000b). E-cadherin-expressing melanoma cells,
when introduced to skin reconstructs (skin equivalents, or-
ganotypic culture), remained in the epidermis and showed
very little invasiveness into the dermis. The downregulation of
E-cadherin and Dsg1 in melanocytes is also associated with
gap junction incompatibility with keratinocytes (Hsu et al,
2000a). Forced expression of E-cadherin restores GJIC be-
tween melanoma cells and keratinocytes (Hsu et al, 2000a).
Therefore, loss of E-cadherin appears to be one of the most
critical steps in progression allowing melanoma cells to es-
cape from the control through keratinocytes.
To dissect the possible mechanisms involved in the E-
cadherin-mediated regulation of melanocytic cells by ker-
atinocytes, a fusion protein between cytoplasmic domain-
truncated E-cadherin and full-length a-catenin (Nagafuchi
et al, 1994) was transduced into melanoma cells. This fusion
gene prevents binding (and signaling) of b-catenin to E-
cadherin while maintaining its adhesive functions and al-
lows adhesion between melanoma cells and keratinocytes
but it does not disrupt signaling for regulation of expression
of melanoma-associated antigens, i.e., expression of Mel-
CAM and b3 integrin was downregulated in the same way as
with wild-type E-cadherin (Li et al, 2004). On the other hand,
if a dominant-negative mutant disrupts adhesion through E-
cadherin, control no longer occurs (Li et al, 2004). These
results suggest a predominant role for E-cadherin for
adhesion. But it has not yet been ruled out whether
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stabilization of b-catenin (and signaling for activation of
TCF/LEF) occurs through the WNT pathway.
The transcriptional mechanisms for keratinocyte-mediated
control over melanocytes and E-cadherin expressing me-
lanoma cells are not yet clear. Cell–cell signaling is likely
controlled by ‘‘master’’ genes that regulate expression of cell-
surface molecules on the melanocytic cells and also control
their growth. It has been shown that the Snail family of tran-
scription factors represses E-cadherin expression and that
Snail family proteins are expressed in melanoma and not
melanocytes (Cano et al, 2000; Poser et al, 2001). The level of
Snail expression correlates directly with the loss of E-cad-
herin expression. Forced expression of Snail in primary me-
lanocytes downregulates E-cadherin expression (Poser et al,
2001). In carcinomas the transcription factor Twist, a master
regulator for embryonic morphogenesis, is overexpressed
and downregulates epithelial markers such as E-cadherin, a-
catenin, and g-catenin and upregulates mesenchymal mark-
ers such as N-cadherin, vimentin, and fibronectin; thus, Twist
contributes to epithelial–mesenchymal transition (Kang and
Massague, 2004; Yang et al, 2004). Furthermore, in me-
lanoma an upregulation of Twist correlated with a poor prog-
nosis (Hoek et al, 2004). Snail and Twist share the same target
in the E-cadherin promoter (Nieto, 2002; Kang and Mass-
ague, 2004), suggesting that Twist represses E-cadherin in
melanoma as well.
Knowledge of the activities of those ‘‘master’’ genes
could help us understand how we may reestablish home-
ostasis in melanoma cells within distant metastases through
‘‘virtual keratinocytes,’’ i.e., we can envision the deve-
lopment of small molecules that provide signals to the
melanoma cells to down-modulate expression of invasion-
related markers and to stop proliferation. Such therapeutic
strategies may lead to stasis, not killing, similar to many
related strategies that interfere with signaling.
Steps in the Melanocyte
Proliferation Cascade
The unique position of melanocytes as singly aligned cells in
the basal layer of the epidermis requires exquisite coordi-
nation for growth with keratinocytes. To better understand
the likely cascade of events during proliferation, one can
dissect them into four steps (Fig 1). The first two steps,
decoupling from keratinocytes and cell division are de-
scribed below in more detail because we know more about
these. The third and fourth steps, migration to separate from
each other and repositioning by extending dendrites into
the upper layers of the epidermis, are still being investigat-
ed. Most likely integrins and morphogens such as Notch
receptors and their ligands play determining roles for these
processes, which are completed when the pigmented cells,
upon stimulation by ultraviolet (UV) light, transport pigment
to the surrounding keratinocytes. For this review, we will
focus on the first two steps of the melanocyte proliferation
cascade and the lessons we can learn for melanoma.
Decoupling of Melanocytes from
Keratinocytes by Hepatocyte Growth Factor
(HGF)-, Platelet-Derived Growth Factor
(PDGF)-, and Endothelin-1 (ET-1)-Mediated
Downregulation of E-Cadherin
In the skin, HGF (or scatter factor) is produced by fibroblasts
for stimulation of keratinocytes and melanocytes. HGF/
c-Met signaling has been implicated in the development of
melanoma (Natali et al, 1993; Hendrix et al, 1998; Rusciano
et al, 1998). HGF stimulates proliferation and motility of hu-
man melanocytes (Halaban et al, 1992; Kos et al, 1999). It is
suggested that autocrine activation of the HGF receptor,
c-Met, induces development of melanoma and acquisition
of the metastatic phenotype (Otsuka et al, 1998). In me-
lanocytes and melanoma cells, HGF decreases expression
of both E-cadherin and desmoglein in a mitogen-activated
protein kinase (MAPK) and PI3-kinase-dependent manner,
leading to decoupling from keratinocytes (Li et al, 2001a). C-
Met forms a complex with E-cadherin, desmoglein, and
Figure 1
Melanocyte homeostasis in normal human
skin. In order to proliferate, melanocytes
need to decouple from the basement mem-
brane and from the keratinocytes, retract their
dendrites (a), divide (b), and migrate along the
basement membrane (c) before they finally
recouple to the matrix and to keratinocytes to
form another epidermal melanin unit (d). Cell
division for melanocytes likely begins with the
upregulation of growth factors produced by
either fibroblasts or keratinocytes, which lead
to downregulation of cadherins and decou-
pling of melanocytes from keratinocytes. Mi-
togenesis is driven by other growth factors
from dermis or epidermis. Migration for repo-
sitioning, anchorage to the basement mem-
brane, recoupling to keratinocytes, dendrite
extension into the upper cell layers, and
growth control by keratinocytes complete
the cycle for melanocytes to maintain a sta-
ble ratio with epidermal keratinocytes.
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plakoglobin (Li et al, 2001a). The functional consequences of
complex formation are not clear. Potentially, E-cadherin can
down-modulate the biological functions of receptor
tyrosine kinases (RTK) (Qian et al, 2004). Besides HGF,
PDGF can also down-modulate E-cadherin in melanocytes
(H. Schaider et al, unpublished), suggesting that the release
of PDGF can also lead to decoupling of melanocytes from
keratinocytes. Similarly, keratinocyte-mediated ET-1 can
downregulate E-cadherin on melanocytes (Jamal and Schn-
eider, 2002). These observations suggest the following: (1)
E-cadherin is a very dynamic molecule that can relatively
easily be down-modulated by microenvironmental factors,
which also might explain why Langerhans cells can freely
migrate through the epidermis despite expression of
E-cadherin which likely allows them to establish communi-
cation with keratinocytes; and (2) changes in the skin
microenvironment that locally enhance growth factor pro-
duction may trigger decoupling of melanocytes from kera-
tinocytes as a first step in deregulated (nevus) proliferation.
Proliferation of Melanocytes and Induction
of Melanocytic Lesions in Human Skin
Grafts with Growth Factors
We tested a variety of growth factors and cytokines for their
ability to stimulate melanocytes in human skin grafted to
immunodeficient SCID or RAG mice using adenoviral vec-
tors for overexpression after intradermal injections (Berking
et al, 2002; Gruss et al, 2003). The virus suspension spreads
in the dermis and infects mostly fibroblasts (Berking et al,
2004). Strongest inducers of melanocyte proliferation were
bFGF (basic fibroblast growth factors or FGF2) and SCF
(stem cell factor or c-kit ligand). After a single injection,
most of the 24 growth factors tested in the absence of UVB-
induced changes in skin, including angiogenesis, matrix
production, fibroblast growth stimulation, epidermal thick-
ening, and/or inflammatory cell infiltration. These prelimi-
nary studies demonstrate that growth factors produced by
dermal cells can stimulate melanocytes at the dermal/
epidermal junction.
Overexpression of bFGF via adenoviral gene transfer in
human skin xenografts led to black-pigmented macules
within 3 wk of treatment which persisted for 8 mo under
continuous weekly bFGF injections (Berking et al, 2001).
Immunofluorescence analysis demonstrated pathological
hyperpigmentation, proliferation, and hyperplasia of acti-
vated melanocytes but no malignant transformation (Ber-
king et al, 2001). When bFGF was combined with UVB,
pigmented lesions with hyperplastic melanocytic cells were
detected, including a lesion with high-grade atypia resem-
bling the lentiginous form of melanoma; this melanoma-like
lesion appeared after approximately 10 wk (Berking et al,
2001). If UVB was replaced by UVA, we did not observe any
UV-mediated effects on the melanocytes. When SCF was
expressed in human skin grafted to SCID mice by intrader-
mal injection, pigmented macules developed with increased
numbers of melanocytes similar to the described effects of
bFGF (Berking et al, 2004), whereas injection of ET-3/Ad5
did not induce striking melanocytic changes. UVB irradia-
tion of the human skin together with the cutaneous expres-
sion of ET-3, SCF, or bFGF had no additional effect on the
melanocytes within a 4 wk observation period. But a com-
bination of bFGF, ET-3, and SCF led to cluster formation of
the melanocytes in the epidermo-dermal junction zone and
to migration of single melanocytes into the upper layers of
the epidermis within 2–4 wk. After one injection of the three
growth factors and three UVB irradiations at 30–50 mJ per
cm2, melanocytes started to proliferate and form nests in
the basement membrane zone. When the weekly induced
expression of all three growth factors bFGF, ET-3, and SCF
was combined with 30–50 mJ per cm2 UVB irradiation three
times weekly, severe pigmented lesions developed (Berking
et al, 2004) (Fig 2). Histologically these lesions were com-
posed of atypical melanocytic cells and represented in situ
melanomas or invasive melanomas resembling invasive and
tumorigenic melanomas in patients’ skin sections. Of the 79
human skin grafts that received the combination treatment,
clinically pigmented lesions were observed in 89% and
melanoma by histopathologic criteria in 34% (Table I).
Immunohistochemical analyses of the lesions revealed
positivity for the melanoma markers S100, HMB45, Melan-
A, and NKIC3. Experimental lesions showed histopatholog-
ical similarities to those in patients. These data suggest that
growth factors and UVB can induce melanoma-like lesions
within a very short time. When adult skin from abdomen,
breast or face was used instead of foreskin, we could also
induce melanoma-like lesions. But these were milder, re-
flecting melanoma in situ. In contrast to foreskin, we could
induce the lesions with growth factors only (Berking et al,
2004). Thus, in adult skin, UVB does not appear to have an
additive effect, which indicates that juvenile skin is more
susceptible to transforming effects by growth factors and
UVB radiation. The correlation of UV and multiple com-
pound nevi in humans might be explained by possibly pre-
existing acquired mutations in adult skin. Whether bFGF,
SCF, and ET-3 are the only growth factors driving me-
lanocyte proliferation synergistically, needs to be estab-
lished. Potentially, other fibroblast or keratinocyte-derived
growth factors or those with endocrine activities can drive
proliferation and disturb the homeostatic balance.
bFGF has well-established functions in melanoma cells
as a self-stimulatory growth factor, which can also be re-
leased by cells for stimulation of the vasculature and for
stroma induction (Bikfalvi et al, 1997). The role of ET-1/ET-3
in melanoma is less clear. ET-1 is secreted by keratinocytes
and stimulates proliferation, chemotaxis, and pigment pro-
duction in melanocytic cells (Yada et al, 1991; Imokawa
et al, 1992; Yohn et al, 1993, 1994; Imokawa et al, 1995,
1996; Horikawa et al, 1996). UV irradiation, which is strongly
linked to melanoma development, induces a marked and
sustained increase in ET-1 secretion by keratinocytes
(Imokawa et al, 1992; Hara et al, 1995; Ahn et al, 1998).
ET-3 is produced by bFGF-stimulated fibroblasts (Berking
et al, 2004). Their receptor, ETB receptor gradually increases
expression as melanocytic lesions progress from nevi to
melanomas, suggesting that the ETB receptor, as well as its
ligands play a role in the tumor progression of melanoma
(Demunter et al, 2001). ETB receptor blockade induces
growth arrest and death of melanoma cells in vivo and
in vitro (Lahav et al, 1999). ETB receptor activation and ca-
spase-8 activation through ET-1, secreted by keratinocytes
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in response to UV irradiation, downregulates E-cadherin in
human melanocytes and melanoma cells (Jamal and Schn-
eider, 2002). In melanoma cells ETB receptor activation by
ET-1 and ET-3 leads to a loss of E-cadherin, b-catenin, and
p120, but to a gain of expression of the transcription factor
Snail, N-cadherin, avb3, and a2b1 integrin and, moreover, to
the activation of the metalloproteinases MMP-2, MMP-9,
and type-1-MMP and to the inhibition of GJIC because of
phosphorylation of connexin 43 (Bagnato et al, 2004).
Moreover, ET-1 upregulates MelCAM in melanocytes (Man-
gahas et al, 2004). All of these findings indicate that ET-1
mediates a variety of responses characteristic for dediffer-
entiation. At present, we cannot integrate in this model the
observation that ET-1 induces dendricity in melanocytes
(Hara et al, 1995), which is generally associated with differ-
entiation. SCF does not appear to play a major role in me-
lanoma, because most tumors show decreased expression
of its receptor, c-kit (Lassam and Bickford, 1992; Natali
et al, 1992; Zakut et al, 1993). Transduction of c-kit into
melanoma cells and stimulation of cells with SCF may lead
to cell death (Huang et al, 1996). In spontaneous melanoma
it is possible that endogenous bFGF replaces exogenous
SCF for stimulation of the appropriate signal transduction
pathways.
Whether UVB induces genetic alterations in melanocytes is
not clear yet but unlikely, because the exposure intensity was
relatively mild and the short duration of the experiments would
likely not induce genetic alteration in cells that promoted cell
growth. Melanocytic cells isolated and cultured from five ex-
perimentally induced lesions formed colonies in soft agar
comparable with cells from established melanoma lines while
normal human melanocytes did not. But colony formation
occurred only if the media were supplemented with the three
growth factors, bFGF, ET-3, and SCF (Berking et al, 2004).
Melanocytic cells isolated and cultured from lesions
showed increased resistance to the growth inhibitory
Figure 2
Melanoma-like lesions in human skin grafts induced by cutaneous expression of basic fibroblast growth factor, endothelin-3, and stem cell
factor combined with irradiation with ultraviolet B. (a–c) Human skin graft on a SCID mouse before (a), 1 wk (b) and 3 wk after beginning of
treatment (c). After 1 wk clinically, a pigmented lesion developed (b), which histologically showed hyperplasia of the epidermis and an increase in
melanocytes, i.e. pigmented melanocytic nests (H&E staining in (d), HMB45 immuno-staining in (f)). After 4 wk melanoma-like lesions developed in
human skin grafts (c), which were composed of big nests of transformed melanocytic cells that already broke through the basement membrane
(H&E staining in (e)) and that stained positive for Melan A (g) and S100 (h).
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effects of TGF-b1 when compared with normal me-
lanocytes. But cultured cells had a finite life span. Similar-
ly, the melanocytic lesions in the human skin grafts
disappeared within 2–5 mo when growth factor injections
and UVB irradiations were terminated.
These experiments established a model of human me-
lanoma in a natural human skin environment that has re-
semblance to melanoma in patients. The lesions and the
cells isolated and cultured from them fulfill most criteria for
malignant transformation including: (1) insensitivity to
growth inhibitory (anti-growth) signals, (2) evasion of pro-
grammed cell death (apoptosis), (3) sustained angiogenesis,
(4) tissue invasion and metastasis. On the other hand, they
continued to remain dependent on exogenous growth fac-
tors and had limited replicative potential, i.e., they senesced
over time. Thus, our challenge is to induce tumorigenic (and
metastatic) melanomas that fulfill all criteria of the ‘‘hall-
marks of cancer’’.
The Genetic Base in Melanoma
The major cancer-related genes, including p53, p16INK4A, or
RAS, are rarely altered in melanoma although the pathways
for these genes may not be biologically functional (reviewed
in Satyamoorthy and Herlyn, 2002; Bogenrieder et al, 2003).
Melanoma cells from advanced stage melanocytic lesions,
including the VGP of primary melanoma are highly an-
euploid, which has hampered a systematic analysis of the
genetic basis of melanoma. The discovery in June of 2002
that the BRAF gene of the MAPK pathway is mutated in
most sporadic melanomas (Brose et al, 2002; Davies et al,
2002) was a major breakthrough in the field. But BRAF is not
only altered in melanoma but also in normal nevi (Pollock
et al, 2003), suggesting that it is important for the switch
from melanocytes to nevi but that additional genetic chang-
es are needed to progress nevi to melanoma. In our me-
lanoma studies it appears that growth factor overexpression
can have synergistic biological effects with activating mu-
tations in BRAF (Satyamoorthy et al, 2003). Thus, we can
determine to what degree cells with BRAF mutations can
become independent of exogenous growth factors. UVB
likely induces additional, as yet unidentified changes at the
biologic and genetic levels. But in contrast to melanoma in
patients, cells in our model remain genetically relatively
stable. Thus, it should be easier to determine specific ge-
netic changes that promote malignant transformation.
Constitutive MAPK Activation in Melanoma
Activation of the MAPK pathway through growth factors that
bind to RTK is a key component of the model of inducing
melanoma-like lesions. Our previous studies with insulin-like
growth factor-1 had implicated that the MAPK pathway
Table I. Pathologic changes in melanocytes in human skin grafts
after 2–4 wk exposure to different growth factor combinations and UVB
Groupa
Growth
factors (n) UVB n
Pigmented
lesionb (%)
Increase of
melanocytesc
Suprabasal
melanocytesd
Melanocytic
nestse
Melanoma-like
lesionsf (%)
bFGFþET-3þSCF 3 þ 79 70/79 (89) 4/5 21 5 17/50 (34)
 7 6/7 4/5 8 2 0
bFGFþET-3 2 þ 5 4/5 1/2 1 0 0
 5 3/5 2/5 6 0 0
bFGFþSCF 2 þ 5 3/5 1/2 2 0 0
 5 3/5 2/5 4 1 0
ET-3þSCF 2 þ 5 0/5 1/4 0 0 0
 5 2/5 2/5 2 0 0
ET-3 1 þ 5 0/5 1/5 0 0 0
 5 0/5 0/5 0 0 0
SCF 1 þ 5 1/5 0/4 1 0 0
 5 3/5 2/4 3 0 0
bFGF 1 þ 6 6/6 6/6 0 0 0
 6 3/6 3/6 0 0 0
GFP/LacZ 0 þ 5 0/5 0/2 0 0 0
 5 0/5 1/4 0 0 0
aGrowth factors bFGF, ET-3, and SCF as well as reporter genes GFP or LacZ were expressed in human skin grafts by weekly injections of the
respective adenoviral vectors. The total dose of each injection was 5  108 PFU per graft in each group regardless of the number of growth factors used.
bDetection of at least one brown or black spot on the skin within 2–4 wk of treatment.
cSignificant increase in HMB45-positive cells compared with non-treated skin grafts.
dAverage number of melanocytic cells per histological section that have left the basement membrane and migrated into the epidermis.
eAverage number of melanocytic nests per histological section. One nest is defined as a cluster of at least four melanocytic cells.
fHistopathological criteria are fulfilled to classify lesion as melanoma or melanoma in situ.
UV, ultraviolet; bFGF, basic fibroblast growth factors; ET-3, endothelin-3; SCF, stem cell factor.
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plays a critical role in melanoma survival and migration (Sat-
yamoorthy et al, 2001a). We tested melanoma cell lines for
Erk1/2 status under several experimental conditions. In nor-
mal melanocytes-activated Erk1/2 were not detectable under
serum-free culture conditions. In contrast, all melanoma cell
lines, regardless of their progression stages, clearly showed
phosphorylated Erk1/2 even in the absence of serum. When
fetal bovine serum was added to the culture medium, the
phosphorylated form of Erk1/2 was induced in normal me-
lanocytes, as well as in RGP and VGP cell lines. None of the
metastatic melanoma lines responded to serum addition. The
constitutive activation of Erk1/2 in melanoma remained under
suspension culture condition. The results of ERK activation in
melanoma were confirmed on lesions of patients. VGP pri-
mary and metastatic melanomas but not nevus lesions ex-
pressed phosphorylated ERK (Satyamoorthy et al, 2003).
The switch from growth factor dependence to independ-
ence is a major tumor progression step in melanoma. Nevi,
which have frequent BRAF mutations (Pollock et al, 2003),
still require exogenous growth factors and have a finite life
span (Mancianti et al, 1988). The switch to growth factor
independence distinguishes non-tumorigenic RGP from
tumorigenic VGP primary melanomas and appears to be
closely related to tumorigenicity and metastatic potential
(Kath et al, 1991). Activation in melanoma of the MAPK
pathway can be because of two mechanisms, autocrine
production of the growth factors bFGF and HGF and
through mutations in the BRAF gene, which occur in over
50% of melanomas (Brose et al, 2002; Davies et al, 2002).
Despite the presence of BRAF mutations in melanoma cells,
inhibition of expression or function of autocrine bFGF and
HGF lead to downregulation of phosphorylation of ERK
suggesting that activation of MAPK pathway members is
because of synergistic activities of growth factors and ge-
netic aberrations in selected genes such as BRAFV600E.
The MAPK pathway is one of several pathways constitu-
tively activated in melanoma cells. As illustrated (Fig 3), me-
lanoma cells show activation, among others, also of the PI3
kinase pathways as well as of STAT3 and NF-kB signaling
suggesting the existence of a number of endogenous or ex-
ogenous triggers. Their dissection will help us to develop
novel strategies for therapy of melanoma. It is anticipated that
successful therapy of melanoma directed at critical signaling
pathways will encompass a combination of inhibitors.
Cell–Cell Communication in Melanoma
Melanoma cells have lost E-cadherin expression but ex-
press high levels of N-cadherin in vitro and in vivo (Fig 4).
The switching of cadherin subtypes during melanoma de-
velopment enables melanoma cells to interact directly with
other N-cadherin-expressing cells such as fibroblasts and
vascular endothelial cells, thus affecting tumor-stroma cell
adhesion, tumor cell invasion and migration, and gene ex-
pression. N-cadherin expression in melanoma cells allows
communication with N-cadherin-expressing fibroblasts
through gap junctions (Hsu et al, 2000a).
The downregulation of E-cadherin in melanocytes is as-
sociated with gap junction incompatibility with keratin-
ocytes (Hsu et al, 2000a). Changes in the connexin
expression, in particular the loss of Cx43, may result in a
reduction or a loss of GJIC, which is thought to contribute
towards tumor progression (reviewed in Haass et al, 2004).
In the skin GJIC is likely to be involved in the regulation of
keratinocyte growth, differentiation, and migration (Pitts
et al, 1988; Salomon et al, 1993; Brissette et al, 1994; Go-
liger and Paul, 1995). We have shown in immunofluores-
cence studies on human tissue, that all areas of melanomas
lack expression of the gap junction molecules connexin 26
(Cx26), Cx30, and Cx43. Interestingly, Cx26 and Cx30 are
induced in the epidermis adjacent to melanomas, but are
absent in the epidermis adjacent to melanocytic nevi (Haass
et al, 2005b). Similarly, in other aggressive skin tumors—
such as Merkel cell carcinoma and invasive areas of
squamous cell, and Bowen’s carcinoma—Cx26 and Cx30
are downregulated as well. There is also an induction of
Cx26 and Cx30 in the epidermis adjacent to these tumors
(Haass et al, 2003, 2005b).
N-cadherin also promotes migration of melanoma cells
over dermal fibroblasts, suggesting that it plays a role in
metastasis. In co-cultures of melanoma cells with fibro-
blasts, N-cadherin co-localizes with zonula occludens pro-
tein-1 (ZO-1) (Smalley et al, 2005). ZO-1 associates with
claudins and occludins, and was first described as a com-
ponent of tight junctions in simple epithelia, endothelia
(Stevenson et al, 1986; Anderson et al, 1988) and, more
recently, in stratified epithelia such as the epidermis (Pummi
et al, 2001; Brandner et al, 2002, 2003; Furuse et al, 2002;
Langbein et al, 2002). But ZO-1 has also been identified in
non-epithelial cells, such as fibroblasts, where it instead
associates with adherens junctions (Itoh et al, 1997; Giep-
mans and Moolenaar, 1998; Yokoyama et al, 2001). In these
cadherin-based adherens junctions, ZO-1 functions as a
cross-linker between a-catenin and the actin cytoskeleton
(Itoh et al, 1997). ZO-1 forms protein–protein complexes
with other molecules involved in cell–cell communication,
such as the gap junction forming connexins (Kausalya et al,
Figure3
Intracellular signaling in melanoma. Binding of growth factors, matrix
molecules, or other cells leads to activation of signaling cascades for
several pathways including the MAPK PI3/AKT, STAT, or NF-kB
pathways as potentially the most important networks with multiple
interactions.
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2001; Laing et al, 2001; Nielsen et al, 2003). Usually ZO-1 is
downregulated in malignant tumors (reviewed in Haass et al,
2004). Recently we demonstrated for the first time that ex-
pression ZO-1 is upregulated in Merkel cell carcinoma (Ha-
ass et al, 2003b) and in both melanoma cell lines and
melanoma samples, and functionally associates with both
N-cadherin and the actin cytoskeleton (Smalley et al, 2005).
RNAi studies reveal that the strength of cell–cell adhesion is
reduced when ZO-1 is knockeddown. In addition, ZO-1 loss
is associated with altered cytoskeletal organization, lack of
long pseudopodia and reduced invasion into collagen gels.
It therefore seems that following cadherin switching, re-
cruitment of increased levels of ZO-1 to N-cadherin-based
junctions may reorganize the cytoskeleton, leading to great-
er invasion (Smallen et al, 2005).
In melanoma cell–melanoma cell interactions, the cell–
cell adhesion molecule Mel-CAM and its unidentified ligand
appear to play a role as co-receptor for N-cadherin, be-
cause its down-modulation disrupts GJIC (Satyamoorthy
et al, 2001b). But Mel-CAM does not have major adhesive
function but is instead involved in invasion and metastasis.
The Melanoma Progression Model—An
Expanding View
Traditionally, the development of melanoma and its pro-
gression is described in six steps: (1) common acquired
melanocytic nevus; (2) melanocytic nevus with lentiginous
melanocytic hyperplasia, i.e., aberrant differentiation; (3)
melanocytic nevus with aberrant differentiation, and me-
lanocytic nuclear atypia, i.e., melanocytic dysplasia; (4) the
RGP of primary melanoma; (5) the VGP of primary me-
lanoma; and (6) metastatic melanoma (Clark et al, 1984).
Our laboratory has defined cells from each progression step
and has established biologic criteria for each step using
unique in vitro and in vivo models. The stepwise progression
model is widely accepted by the scientific community and
many researchers have contributed to knowledge on the
genetic, biologic, and molecular events that drive progres-
sion. Major gaps in knowledge still exist in tumor- and host-
derived factors that progress melanoma cells from the RGP
to the VGP step, a progression step that is most critical for
clinical outcome of the disease. Most melanomas arise
within the epidermis (melanoma in situ) and then invade
across the basement membrane region. There may in ad-
dition be rare melanomas that arise de novo in the dermis in
a subset of nodular melanomas and other at least equally
rare melanomas that arise in the dermis in association with
a pre-existing congenital nevus. Many melanomas (perhaps
30%–50%) arise in association with a putative precursor
lesion as judged histologically. On the other hand, tumors
arising without clinical precursor lesions represent approx-
imately 50% of all sporadic melanoma cases and we have a
limited understanding of the events that occur when me-
lanomas arise without clinically defined precursor stages
(Fig 5). We are currently exploring whether melanomas can
arise from melanocyte precursor cells hypothesizing that
such cells may transform without passing through the
‘‘classical’’ progression steps. The immature phenotype of
melanoma cells may not necessarily come from dediffer-
entiation (this view) but also from transformation of me-
lanocyte stem cells or precursor cells.
Fibroblasts within the tumor stroma may play an impor-
tant role for progression of melanomas from RGP to VGP or
from VGP to metastasis. We are currently testing the hy-
pothesis that fibroblasts and their cross-talk to tumor cells
are critical for disease outcome. We expect that fibroblasts
infiltrating into tumors can be targeted for melanoma
therapy because our preliminary investigations have
demonstrated that their presence is essential for tumor
Figure 4
Cell–cell communication in melanoma. Normal epidermal me-
lanocytes interact with adjacent keratinocytes through E-cadherin,
desmoglein 1, and connexins (a). A shift of the cadherin profile from E-
to N-cadherin during melanoma development not only frees the cells
from epidermal keratinocytes, but also confers new adhesive and
communication properties. Melanoma cells interact with each other (b)
through N-cadherin, Mel-CAM/Mel-CAM ligand, avb3 integrin/L1-CAM,
ALCAM (Degen et al, 1998; van Kempen et al, 2000) and connexins,
with fibroblasts (c) through N-cadherin and connexins, and with end-
othelial cells (d) through N-cadherin, Mel-CAM/Mel-CAM ligand, avb3
integrin/L1-CAM, a4b1 integrin/VCAM-1 (reviewed in Holzmann et al,
1998), and connexins.
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expansion beyond an initial cell cluster. We also expect that
fibroblasts in the dermis have a major role in melanocyte
stem cell differentiation and that their dysregulation initiates
tumor formation. Furthermore, we expect that stromal fib-
roblasts play a role in melanoma stem cell maintenance,
most likely through the production of growth factors. Iden-
tification of melanoma stem cells should lead to new strat-
egies for induction of differentiation of the most aggressive
subpopulations within a tumor.
We are developing an expanding view on the role of
endothelial cells in melanoma progression and metastasis.
The cell type traditionally thought to be involved in the
tumor vascularization is the microvascular endothelial cell,
previously believed to derive primarily from resident tissue
such as skin. But circulating endothelial precursor cells
were isolated from adult blood and bone marrow and once
they become adherent in vitro these cells differentiated into
mature endothelial cells (Asahara et al, 1997). The precursor
cells were found in the endothelial cell population of devel-
oping tumors, healing wounds, ischemic myocardium, and
ischemic hind limbs (Asahara et al, 1997, 1999; Takahashi
et al, 1999). Locally transplanted autologous bone marrow-
derived mononuclear cells that contain endothelial precur-
sor cells survived and were successfully incorporated into
the capillary endothelial networks during active angiogen-
esis in vivo and augmented neo-vascularization and collat-
eral vessel formation (Kamihata et al, 2001). Most recent
data define a dendritic precursor cell that can develop into
endothelial cells as it infiltrates tumors (Conejo-Garcia et al,
2004, 2005). The endothelial-like cells may have also retain
some of their original immunological functions such as an-
tigen presentation suggested that the tumors represent an
‘‘organ’’ with complex intercellular communications and that
tumor progression may in large parts depend on appropri-
ate cooperation or submission of the normal cell compo-
nents.
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